Net Income (Loss) Attributable to Parent in USD of Eloxx Pharmaceuticals, Inc. from 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Eloxx Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from 2010 to Q3 2023.
  • Eloxx Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2023 was -$3.59M, a 52.2% increase year-over-year.
  • Eloxx Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2023 was -$20.5M, a 51% increase year-over-year.
  • Eloxx Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$36.1M, a 46% increase from 2021.
  • Eloxx Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$66.7M, a 93% decline from 2020.
  • Eloxx Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$34.6M, a 32% increase from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Eloxx Pharmaceuticals, Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$20.5M -$3.59M +$3.92M +52.2% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2023
Q2 2023 -$24.4M -$4.34M +$6.28M +59.1% 01 Apr 2023 30 Jun 2023 10-Q 13 Nov 2023
Q1 2023 -$30.7M -$6.23M +$5.39M +46.4% 01 Jan 2023 31 Mar 2023 10-Q 13 Nov 2023
Q4 2022 -$36.1M -$6.32M +$5.77M +47.7% 01 Oct 2022 31 Dec 2022 10-K 31 Mar 2023
Q3 2022 -$41.8M -$7.51M +$2.38M +24% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023
Q2 2022 -$44.2M -$10.6M +$25.4M +70.6% 01 Apr 2022 30 Jun 2022 10-Q 13 Nov 2023
Q1 2022 -$69.7M -$11.6M -$2.93M -33.7% 01 Jan 2022 31 Mar 2022 10-Q 13 Nov 2023
Q4 2021 -$66.7M -$12.1M -$5.96M -97.3% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 -$60.8M -$9.89M -$3.27M -49.4% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 -$57.5M -$36.1M -$28.2M -357% 01 Apr 2021 30 Jun 2021 10-Q 10 Nov 2022
Q1 2021 -$29.3M -$8.69M +$5.25M +37.7% 01 Jan 2021 31 Mar 2021 10-Q 10 Nov 2022
Q4 2020 -$34.6M -$6.13M +$5.51M +47.3% 01 Oct 2020 31 Dec 2020 10-K 30 Mar 2022
Q3 2020 -$40.1M -$6.62M +$6.26M +48.6% 01 Jul 2020 30 Sep 2020 10-Q 08 Nov 2021
Q2 2020 -$46.3M -$7.89M +$6.56M +45.4% 01 Apr 2020 30 Jun 2020 10-Q 08 Nov 2021
Q1 2020 -$52.9M -$13.9M -$2.03M -17% 01 Jan 2020 31 Mar 2020 10-Q 08 Nov 2021
Q4 2019 -$50.9M -$11.6M +$2.39M +17.1% 01 Oct 2019 31 Dec 2019 10-K 30 Mar 2022
Q3 2019 -$53.3M -$12.9M -$1.71M -15.4% 01 Jul 2019 30 Sep 2019 10-Q 06 Nov 2020
Q2 2019 -$51.6M -$14.4M -$1.04M -7.78% 01 Apr 2019 30 Jun 2019 10-Q 06 Nov 2020
Q1 2019 -$50.5M -$11.9M -$3.33M -38.7% 01 Jan 2019 31 Mar 2019 10-Q 06 Nov 2020
Q4 2018 -$47.2M -$14M -$3.43M -32.3% 01 Oct 2018 31 Dec 2018 10-K 12 Mar 2021
Q3 2018 -$43.8M -$11.2M -$7.12M -176% 01 Jul 2018 30 Sep 2018 10-Q 06 Nov 2019
Q2 2018 -$36.6M -$13.4M -$9.53M -246% 01 Apr 2018 30 Jun 2018 10-Q 06 Nov 2019
Q1 2018 -$27.1M -$8.59M -$5.91M -221% 01 Jan 2018 31 Mar 2018 10-Q 06 Nov 2019
Q4 2017 -$21.2M -$10.6M -$9.81M -1242% 01 Oct 2017 31 Dec 2017 10-K 16 Mar 2018
Q3 2017 -$11.4M -$4.04M -$3.11M -333% 01 Jul 2017 30 Sep 2017 10-Q 08 Nov 2018
Q2 2017 -$8.28M -$3.88M 01 Apr 2017 30 Jun 2017 10-Q 10 Aug 2018
Q1 2017 -$2.68M +$401K +13% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018
Q4 2016 -$790K +$3.07M +79.5% 01 Oct 2016 31 Dec 2016 10-Q 10 Feb 2017
Q3 2016 -$934K -$753K -417% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017
Q1 2016 -$3.08M -$1.85M -151% 01 Jan 2016 31 Mar 2016 10-Q 22 May 2017
Q4 2015 -$3.86M +$6.89M +64.1% 01 Oct 2015 31 Dec 2015 10-Q 10 Feb 2017
Q3 2015 -$181K +$5M +96.5% 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016
Q1 2015 -$20.8M -$1.23M +$920K +42.8% 01 Jan 2015 31 Mar 2015 10-Q 12 May 2016
Q4 2014 -$21.8M -$10.7M -$9.13M -563% 01 Oct 2014 31 Dec 2014 10-Q 16 Feb 2016
Q3 2014 -$12.6M -$5.18M -$3.4M -191% 01 Jul 2014 30 Sep 2014 10-Q 16 Nov 2015
Q2 2014 -$9.23M -$3.67M -$1.74M -90.3% 01 Apr 2014 30 Jun 2014 10-K 13 Oct 2016
Q1 2014 -$7.48M -$2.15M -$1.31M -157% 01 Jan 2014 31 Mar 2014 10-Q 14 May 2015
Q4 2013 -$6.17M -$1.62M -$350K -27.5% 01 Oct 2013 31 Dec 2013 10-Q 17 Feb 2015
Q3 2013 -$5.82M -$1.78M +$301K +14.4% 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2014
Q2 2013 -$6.12M -$1.93M -$492K -34.2% 01 Apr 2013 30 Jun 2013 10-K 09 Oct 2015
Q1 2013 -$5.63M -$837K +$224K +21.1% 01 Jan 2013 31 Mar 2013 10-Q 09 May 2014
Q4 2012 -$5.85M -$1.27M +$258K +16.9% 01 Oct 2012 31 Dec 2012 10-Q 14 Feb 2014
Q3 2012 -$6.11M -$2.09M -$1.05M -101% 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2013
Q2 2012 -$5.07M -$1.44M +$1.27M +46.9% 01 Apr 2012 30 Jun 2012 10-K 29 Sep 2014
Q1 2012 -$6.34M -$1.06M +$344K +24.5% 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013
Q4 2011 -$6.68M -$1.53M -$391K -34.4% 01 Oct 2011 31 Dec 2011 10-Q 14 Feb 2013
Q3 2011 -$6.29M -$1.04M +$976K +48.5% 01 Jul 2011 30 Sep 2011 10-Q 14 Nov 2012
Q2 2011 -$7.27M -$2.71M 01 Apr 2011 30 Jun 2011 10-K 11 Sep 2013
Q1 2011 -$1.41M 01 Jan 2011 31 Mar 2011 10-Q 14 May 2012
Q4 2010 -$1.14M 01 Oct 2010 31 Dec 2010 10-Q 14 Feb 2012
Q3 2010 -$2.02M 01 Jul 2010 30 Sep 2010 10-Q 14 Nov 2011

Eloxx Pharmaceuticals, Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$36.1M +$30.7M +46% 01 Jan 2022 31 Dec 2022 10-K 31 Mar 2023
2021 -$66.7M -$32.2M -93% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023
2020 -$34.6M +$16.3M +32% 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2022
2019 -$50.9M -$3.69M -7.82% 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2022
2018 -$47.2M -$26M -122% 01 Jan 2018 31 Dec 2018 10-K 12 Mar 2021
2017 -$21.2M -$11.4M -115% 01 Jan 2017 31 Dec 2017 10-K 06 Mar 2020
2016 -$9.85M -$3.44M -53.7% 01 Jan 2016 31 Dec 2016 10-K 14 Mar 2019
2015 -$6.41M +$2.82M +30.6% 01 Jan 2015 31 Dec 2015 10-K 16 Mar 2018
2014 -$9.23M -$3.1M -50.7% 01 Jul 2013 30 Jun 2014 10-K 13 Oct 2016
2013 -$6.12M -$1.06M -20.9% 01 Jul 2012 30 Jun 2013 10-K 09 Oct 2015
2012 -$5.07M +$2.2M +30.3% 01 Jul 2011 30 Jun 2012 10-K 29 Sep 2014
2011 -$7.27M +$6.11M +45.7% 01 Jul 2010 30 Jun 2011 10-K 11 Sep 2013
2010 -$13.4M 01 Jul 2009 30 Jun 2010 10-K 11 Sep 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.